Thomas Bukur

6PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersNanomedicineMolecular targetsEvolution of developmental systemsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 22, 2024
TF-FVIIa PAR2-β-Arrestin Signaling Sustains Organ Dysfunction in Coxsackievirus B3 Infection of Mice.

Meike Kespohl, Carl Christoph Goetzke, Nadine Althof

|Jun 28, 2023
CoVigator-A Knowledge Base for Navigating SARS-CoV-2 Genomic Variants.

Thomas Bukur, Pablo Riesgo-Ferreiro, Patrick Sorn

|Mar 29, 2023
Characterization of BV6-Induced Sensitization to the NK Cell Killing of Pediatric Rhabdomyosarcoma Spheroids.

Vinzenz Särchen, Lisa Marie Reindl, Sara Wiedemann

|Sep 27, 2021
Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates.

Barbara Schrörs, Pablo Riesgo-Ferreiro, Patrick Sorn

|Jan 08, 2021
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis.

Christina Krienke, Laura Kolb, Elif Diken

|Jan 04, 2020
An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors.

Katharina Reinhard, Benjamin Rengstl, Petra Oehm

Pageof 1

Frequent Collaborators

2 joint publications

Özlem Türeci

2 joint publications

Pablo Riesgo-Ferreiro

1 joint publications

Katharina Reinhard

1 joint publications

Benjamin Rengstl